Na Cocer Peptides bin rayt am 
1 mɔnt dɔn pas
ƆL DI ATIKUL ƐN PRODƆKT INFƆMƐSHƆN WE DƐN GI NA DIS WƐBSAYT NA FƆ ƆL FƆ DI INFƆMƐSHƆN ƐN FƆ EDYUKESHƆN.
Di prɔdak dɛn we dɛn gi na dis wɛbsayt na fɔ in vitro risach nɔmɔ. in vitro risach (Latin: *in glas*, we min insay glas) dεn de du am ausayd mכtalman bכdi. Dɛn prɔdak ya nɔto mɛrɛsin, dɛn nɔ gɛt di aprɔval frɔm di US Food and Drug Administration (FDA), ɛn dɛn nɔ fɔ yuz dɛn fɔ protɛkt, trit, ɔ mɛn ɛni mɛrɛsin, sik, ɔ sik. Di lɔ nɔ gri fɔ mek dɛn put dɛn tin ya insay mɔtalman ɔ animal bɔdi ɛni we.
1. Introdukshɔn
We yu de du ɛksɛsayz, bɔku tɛm we yu taya, dat kin mek yu nɔ ebul fɔ bia wit ɛksesaiz. di nכmal fכnshכn fכ di enεji mεtabolism path dεm implεnt fכ mεnten di εksεsayz kapasiti. as pכtεnshal rεgεdyushכn fכktכ, di rol we Vilon de ple fכ di enεji mεtabolism path dεn dכn atrak atεnshכn sכmtεm.
fig 1 di enεji mεtabolism de rεgεl tru wan signal path we kכnsis fכ AMPK εn in dכwnstrim rilayt fכktכ dεm.
2. Di Rilayshɔn Bitwin Ɛnaji Mɛtabolism Pathways ɛn Ɛksesaiz Fatigue ɛn Endurance
(1) Ovaviu fכ di Enεji Mεtabolism Pathways
We yu de du ɛksɛsayz, di ɛnaji we di bɔdi de gi de dipen mɔ pan di mɛtabolism fɔ di kabɔhaydrɛt, fat, ɛn prɔtin dɛn. di mεtabolism fכ di kכbaidret de ple wan kכl rol fכ lכng εndurans εksεsayz, we de gi enεji tru glycolysis εn aerobic oxidation pathways. di mεtabolism fכ fεt de wok lεk sataynabul enεji sכs, we de εp fכ kip di limited kכbhaydret rεsכv dεm. di protin dεm de kכntribyut bak wan pat pan di enεji we dεn de du fכ lכng εndurans εksεsayz, we de akכnt fכ lεk 10% pan di tכtal ATP prodakshכn.
(2) Di Rilayshɔn Bitwin Ɛksesaiz Fatigue ɛn Ɛnaji Mɛtabolism
we yu du εksεsayz fכ lכng tεm i kin mek di εnεji mεtabolism imbalans, lεk di blכd glukכs lεvεl dεm we de dכn εn di glycogen rizכv dεm we de dכn, we de kכmכn wit di akyumyuleshכn fכ mεtabolik bayprodukt dεm lεk laktik asid εn bכdi amonia. Dɛn chenj ya kin mek pɔsin taya fɔ du ɛksɛsayz ɛn i kin mek i nɔ ebul fɔ bia wit ɛksesaiz.
Di Rɛgyulatɔri Rol we Vilɔn gɛt pan Ɛnaji Mɛtabolism Pathways
(1) Vilon in Rɛgyuleshɔn fɔ Kabɔhaydrɛt Mɛtabolism
glycogen sεntesis εn brεkdכwn: Vilon kin infכlכw glycogen sεntesis εn brεk dכwn bay we i de rεgεl di aktiviti fכ di kכl εnzym dεm lεk glycogen synthase (GS) εn glycogen phosphorylase. bifo yu du εksεsayz, Vilon de mek di glycogen sεntesis, we de mek di glycogen rizכv dεm go כp; we yu de du εksεsayz, Vilon kin rεgεl di rεt we di glycogen de brok dכn fayn fayn wan fכ mek sכh se di blכd glukכs saplai stebul. insay maws εkspεriεns, mays dεm we dεn trit wit Vilon sho mכr rizin chenj dεm na di glycogen kכntεnt na di mכsul dεm εn liva bifo εn afta εksεsayz, bεtε mεnten di εnεji we dεn nid we dεn de εksεsayz.
glycolysis εn aerobic oksidashכn: Vilon kin infכlכw di aktiviti fכ di kכl εnzym dεm na di glycolytic path, lεk fכsfruktokinase (PFK), we de rεgεl di rεt fכ glycolysis. Vilon kin tek pat bak fכ rεgεl di aktvכti fכ di εnzym dεm we riliyt to di trikarbכksilik asid saykl insay aerobik כksidεshכn, lεk saytεt sεntez (CS), we de optimiz aerobik כksidεshכn fכ kכbhaydrεt fכ enεji prodakshכn εn impruv εnεji yutilizeshכn efyushכn.
(2) Rεgulεshכn כf Fεt Mεtabolism bay Vilon
fεt asid mobilizεshכn εn transpכt: vaylכn kin protεkt fεt asid mobilizεshכn insay adipos tisu bay we i de rεgεl di aktiviti fכ εnzym dεm lεk כmon-sεnsitiv laypas (HSL). vaylכn kin infכlכw bak di εksprεshכn fכ fεt asid transpכrta dεm (FATP), we de aksεlεrayt di transpכt fεt asid to mכsul sεl dεm εn gi mכr sabstεrayt fכ mכsul כksidεtiv εnεji prodakshכn.
β-Oksidashכn: insay di mכsul sεl dεm, Vilon kin rεgεl di aktiviti fכ di kכl εnzym dεm lεk carnitine palmitoyltransferase (CPT), we de protεkt di β-oksidashכn fכ fεt asid dεm, impruv di efyushכn fכ fεt כksidεshכn fכ enεji prodakshכn, rεdכks di kכnsכmshכn fכ kכbhaydret, εn dat de mek di εksεsayz εndurans.
(3) Rεgulεshכn כf Protεin Mεtabolism bay Vilon
pan tap we di protin dεm de akכnt fכ sכm sכm pat pan di enεji saplai we dεn de du εksεsayz, Vilon kin rεgεl di rilayt signal path dεm fכ ridyus di protin dεgradashכn, we de mek di mכsul dεm mεnten εn fכnshכn. vaylכn kin inhεbit di aktiviti fכ di ubiquitin-proteasome sistεm, we de ridyus di mכsul protin dεgradashכn, we de εp fכ mεnten di mכsul dεm kכntraktiliti εn fכ mek di εksεsayz taya.
Vilon in Rol fכ Rεgεl Enεji Mεtabolism Pathways fכ Fatigue Resistance εn Exercise Endurance Improvement
(1) Ifɛkt dɛn we de mek pɔsin taya
Dilay we di mεtabolism de bigin: bay we i de rεgεl di εnεji mεtabolism path dεm, Vilon kin mεnten stebul saplai fכ enεji sכbstans dεm lεk bכdi glukכs εn glycogen, ridyus di akyumyuleshכn fכ di mεtabolik bayprodukt dεm, εn dat de mek i delay di biginin fכ taya. Insay animal ɛkspiriɛns, animal dɛn we dɛn trit wit Vilon sho se dɛn taya we dɛn de du ɛksɛsayz fɔ lɔng tɛm.
Ridyus di taya we dɛn kin taya: Di wan dɛn we dɛn trit wit Vilon bin sho se dɛn gɛt smɔl smɔl bayɔkemik mak dɛn we gɛt fɔ du wit taya lɛk laktat ɛn blɔd yuria naytrɔjen (BUN) na dɛn blɔd afta dɛn dɔn du ɛksɛsayz, we sho se Vilon kin ridyus di kayn we aw dɛn kin taya we dɛn de du ɛksɛsayz ɛn i kin mek dɛn wɛl kwik kwik wan.
(2) Fɔ mek pɔsin ebul fɔ bia wit ɛksesaiz
εkstend εksεsayz durashכn: biכs fכ Vilon in optimizεd rεguleshכn fכ di εnεji mεtabolism path dεm, di bכdi kin yuz εnεji sabstεrayt dεm mכr efyushכn, we de mek di εksεsayz dεryushכn εkstend. Bɔku stɔdi dɛn dɔn sho se animal dɛn we dɛn gi Vilon sho se di tɛm we dɛn de du ɛksɛsayz bɔku bɔku wan we dɛn de du ɛksɛsayz.
Ɛnjɔy ɛksɛsayz: Vilɔn nɔ jɔs de mek di ɛksesaiz lɔng bɔt i de ɛp fɔ mek di ɛksesaiz strɔng te to sɔm mak. dis kin bi biכs Vilon de impruv enεji mεtabolism, we de mek di mכsul dεm fכ gεt inof enεji saplai we dεn de du hεy-intensiti εksεsayz fכ mεnten di mכsul dεm we de kכntrikshכn fכ wok.
Dɔn
vaylכn de ple imכtant rol fכ taya rεsistεns εn εksεsayz εndurans εnhansmεnt tru in mכltifays rεguleshכn fכ kכbahaydret, fεt, εn protin mεtabolism insay εnεji mεtabolik path dεm. I kin delay di biginin fɔ taya, ridyus di taya we yu taya, pan ɔl we i kin mek yu ɛksesaiz lɔng ɛn i kin mek yu ebul fɔ du ɛksɛsayz.
Sos dɛn we dɛn pul
[1] Zhao R, Wu R, Jin J, ɛn ɔda pipul dɛn. signal path dεm we nεchכral aktv ingridiεnt dεm de rεgεl insay di fכt εgεst εksεsayz fεt-a rivyu[J]. Frɔntiers in Famakɔlɔji, 2023,Vɔlyum 14 - 2023.DOI: 10.3389/fphar.2023.1269878.
[2] Li M, Hsu Y, Shen S, ɛn ɔda pipul dɛn. wan fכnshכnal evalueshכn fכ anti-fatigue εn εksεsayz pεrformεns improvεmεnt fכlכw vaytam in B kכmpleks supliment in hεlty hכman, wan randomizεd dכbl-blaynd trayal[J]. Int ɛ rnash ɔ nal J ɔ rnal ɔ f M ɛ dikal Sayns, 2023,20:1272-1281.
[3] Zhong H, Shi J, Zhang J, ɛn ɔda pipul dɛn. Soft-Shelled Turtle Peptide Supplementation Modify Energy Mεtabolism εn Oxidative Stress, I de εnhans εksεsayz εndurans, εn dεkrεs fכshal fεtigue in mays[J]. Fɔd, 2022,11(4).DOI:10.3390/fud11040600.
[4] Huang J, Tagawa T, Ma S, ɛn ɔda pipul dɛn. Blak Jinja (Kaempferia parviflora) Ekstrakt de εnhans εndurans kapasiti bay we i de impruv εnεji mεtabolism εn sabstεrayt yutilayzεshכn insay mays[J]. Nutrients, 2022,14(18).DOI:10.3390/nu14183845. Di wan dɛn we de wok fɔ di bɔdi.
[5] Alghannam AF, Ghaith MM, Alhussain M H. Rεgulεshכn כf εnεji Sabstrεt Mεtabolism in εndurεns εksεsayz[J]. Int ɛ rnash ɔ nal J ɔ rnal ɔ f Envayrɔmɛnt Risach ɛn Pɔblik Ɛlth, 2021,18(9).DOI:10.3390/ijerph18094963.
[6] Xu X, Ding Y, Yang Y, ɛn ɔda pipul dɛn. β-glucan Salecan Impruv Eksεsayz Pεrformεns εn Display Anti-Fεtigue Efεkt tru Rεgulεt εnεji Mεtabolism εn Oksidativ Strεs in Mays[J]. Nutrients, 2018,10(7).DOI:10.3390/nu10070858. Di wan dɛn we de wok fɔ di bɔdi.
Prodak we de fɔ yuz fɔ risach nɔmɔ:
